The Head of the Public Relations Unit at the NPHCDA, Remi Adeleke, who disclosed this also stated that the vaccine deployment will begin from October 3 to 6, 2024.
Adeleke said the date for vaccine deployment based on the current chronogram is from October 3 to 6, 2024, time to align with the three to six weeks period from vaccine receipt on August 27 for NAFDAC to conclude the regulatory procedures of sampling, traceability and lab analysis.
Adeleke added that the total population targeted in the five states is 4,750 persons, who will receive two doses each, 28 days apart.
He clarified that the target population is Close contact of Mpox cases, health workers, and persons with low immune status.
On the strategy to deploy, the head of the PRU said two sites per state are to be identified for vaccination.
He added that additional doses of the Mpox vaccine to be received are still being determined by the service delivery team so that the country can benefit from the available stock from the Africa CDC planned donation.